Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.

US Patent 7198788 · Granted Apr 3, 2007

Estimated economic value: $140,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer treatment composition combining anti-CD26 antibody and other anticancer a2022
Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof2018
Method of treating malignant mesothelioma2014
Anti-CD26 antibodies and methods of use thereof2011
Methods of identifying immunoregulatory agents, immunoregulatory agents, and use2010
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells ex2010
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells ex2010
Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells ex2010
Anti-CD26 antibodies and methods of use thereof2008
Regulation of immune responses by attractin2005
Form of dipeptidylpeptidase IV (CD26) found in human serum2001
Form of dipeptidylpeptidase IV (CD26) found in human serum2001